Word

Status

Pending

Status Code

661

Status Date

Wednesday, March 13, 2024

Serial Number

97691802

Mark Type

2000

Filing Date

Friday, November 25, 2022

Trademark Owner History

ENHANC3D GENOMICS LTD

Classifications

9 Downloadable software for profiling 3D genome folding at high resolution for all genes and their enhancers; Downloadable software for visualisation, analysis, and manipulation of biological molecules in the field of genomics; Downloadable software for visualisation, analysis, and manipulation of biological molecules; Downloadable software for modelling and prediction of biological interactions; Downloadable software for genome sequencing; Scientific research apparatus and instruments for profiling 3D genome folding at high resolution for all genes and their enhancers; Electronic database in the field of genomics recorded on computer media; Downloadable educational publications, namely, printable workbooks, booklets, reviews, scientific journals, and articles in the field of genomics; Downloadable electronic publications in the nature of scientific journals, articles, and reviews in the field of drug discovery; Downloadable electronic publications in the nature of scientific journals, articles, and reviews in the field of medical diagnosis; Downloadable electronic publications in the nature of scientific journals, articles, and reviews in the field of biomarker discovery; Downloadable electronic publications in the nature scientific journals, articles, and reviews in the field of genomics; Downloadable electronic publications in the nature of scientific journals, articles, and reviews in the field of bioinformatics

36 Financial data analysis; Financial data analysis in the field of drug discovery; Financial data analysis in the field of medical diagnosis; Financial data analysis in the field of biomarker discovery; Financial data analysis in the field of genomics; Financial data analysis in the field of bioinformatics

35 Business data analysis; Business data analysis in the field of drug discovery; Business data analysis in the field of medical diagnosis; Business data analysis in the field of biomarker discovery; Business data analysis in the field of genomics; Business data analysis in the field of bioinformatics; Data processing; Data processing in the field of drug discovery; Data processing in the field of medical diagnosis; Data processing in the field of biomarker discovery; Data processing in the field of genomics; Data processing in the field of bioinformatics; Database management; Database management and reporting services; Business information services; Business consulting services; Business consulting services in the field of drug discovery; Business consulting services in the field of biomarker discovery; Market intelligence services; Electronic data collection and data submission services for business purposes in the fields of medicine and healthcare; Compilation of data for use in scientific research; Information, advisory and consultancy services in relation to all of the aforesaid

42 Software as a service (SAAS) services for profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Software as a service (SAAS) services featuring software for research and development of drugs in the field of genomics; Software as a service (SAAS) services featuring software for diagnosis of genetic diseases; Software as a service (SAAS) services featuring software for development of biomarkers for medical treatment; Software as a service (SAAS) services featuring software for collection, analysis and interpretation of biological data; Software as a service (SaaS) services featuring software for visualisation, analysis, and manipulation of biological molecules; Software as a service (SaaS) services featuring software for modelling and prediction of biological interactions; Software as a service (SaaS) services featuring software for genome sequencing; Software as a service (SAAS) services featuring software for data analysis, data processing and database management in the field of genomics; Software as a service (SAAS) services featuring software for research and development of artificial intelligence and machine learning the field of genomics; Platform as a service (PAAS) featuring computer software platforms for data analysis, data processing and database management in the field of genomics; Platform as a service (PAAS) featuring computer software platforms for research and development of drugs in the field of genomics; Platform as a service (PAAS) featuring computer software platforms for diagnosis of genetic diseases; Platform as a service (PAAS) featuring computer software platforms for development of biomarkers for medical treatment; Platform as a service (PAAS) featuring computer software platforms for profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Platform as a service (PAAS) featuring computer software platforms for collection, analysis and interpretation of biological data; Platform as a service (PaaS) featuring computer software platforms for visualisation, analysis, and manipulation of biological molecules; Platform as a service (PaaS) featuring computer software platforms for modelling and prediction of biological interactions; Platform as a service (PaaS) featuring computer software platforms for genome sequencing; Platform as a service (PaaS) featuring computer software platforms in the field of data analysis, data processing, and database management; Platform as a service (PaaS) featuring computer software platforms in the field of artificial intelligence and machine learning; Design and development of software for profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Design and development of software in the field of drug discovery; Design and development of software in the field of medical diagnosis; Design and development of software in the field of biomarker discovery; Design and development of software in the field of genomics; Design and development of software in the field of bioinformatics; Design and development of software for visualisation, analysis, and manipulation of biological molecules; Design and development of software for modelling and prediction of biological interactions; Design and development of software for genome sequencing; Design and development of software in the field of data analysis; Design and development of software in the field of artificial intelligence and machine learning; Scientific research services for others in the field of genomics; Scientific research services for others in the field of drug discovery; Scientific research services for others in the field of medical diagnosis; Scientific research services for others in the field of biomarker discovery; Scientific research services for others in the field of genomics; Scientific research services for others in the field of bioinformatics; Scientific research consulting services; Scientific research consulting services in the field of drug discovery; Scientific research consulting services in the field of medical diagnosis; Scientific research consulting services in the field of biomarker discovery; Scientific research consulting services in the field of genomics; Scientific research consulting services in the field of bioinformatics; Scientific and technological services, namely, profiling three-dimensional genome folding at high resolution for all genes and their enhancers, in the field of genomics; Scientific and technological services, namely, scientific testing in the field of drug discovery; Scientific and technological services, namely, scientific testing in the field of medical diagnosis; Scientific and technological services, namely, scientific testing in the field of biomarker discovery; Scientific and technological services, namely, scientific testing in the field of genomics; Scientific and technological services, namely, scientific testing in the field of bioinformatics; Computer services for the analysis of data for scientific purposes; Providing temporary use of on-line non-downloadable software for profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Information, advisory and consultancy services in relation to all of the aforesaid

The mark consists of a series of three linked and closed loops forming an irregular helix with a smaller fourth linked and closed loop at the right end of the series of three loops.
Color is not claimed as a feature of the mark.

Trademark Events

Mar 13, 2024

Teas/Email Correspondence Entered

Mar 13, 2024

Correspondence Received In Law Office

Mar 13, 2024

Teas Response To Office Action Received

Dec 13, 2023

Application Extension Granted/Receipt Provided

Dec 13, 2023

Application Extension To Response Period - Received

Sep 18, 2023

Notification Of Non-Final Action E-Mailed

Sep 18, 2023

Non-Final Action E-Mailed

Sep 18, 2023

Non-Final Action Written

Sep 6, 2023

Assigned To Examiner

Dec 20, 2022

Notice Of Design Search Code E-Mailed

Dec 18, 2022

New Application Office Supplied Data Entered

Nov 29, 2022

New Application Entered